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Accepted 20 September 2020The prevalence of Loa loa, Onchocerca volvulus and Wuchereria bancrofti infections in an under-
surveyed area of Bengo Province, Angola, was determined by surveying 22 communities with a
combination of clinical, serological and DNA diagnostics. Additional information was collected
on participants' duration of residency, access to mass drug administration, knowledge of insect
vectors and use of bednets. A total of 1616 individuals (38.1% male: 61.9% female), with an av-
erage age of 43 years, were examined. For L. loa, 6.2% (n = 100/16616) individuals were found
to have eyeworm, based on the rapid assessment procedure for loiasis (RAPLOA) surveys, and
11.5% (n =178/1543) based on nested PCR analyses of venous blood. L. loa prevalences in long-
term residents (>10 years) and older individuals (>60 years) were significantly higher, and
older men with eyeworm were better informed about Chrysops vectors. For O. volvulus, 4.7%
(n = 74/1567) individuals were found to be positive by enzyme-linked immunosorbent
assay (Ov 16 ELISA), with only three individuals reporting to have ever taken ivermectin. For
W. bancrofti, no infections were found using the antigen-based immunochromatographic test
(ICT) and real-time PCR analysis; however, 27 individuals presented with lymphatic filariasis
(LF) related clinical conditions (lymphoedema = 11, hydrocoele = 14, both = 2). Just under
half (45.5%) of the participants owned a bednet, with the majority (71.1%) sleeping under it
the night before. Our approach of using combination diagnostics reveals the age-prevalence
of loiasis alongside low endemicity of onchocerciasis and LF. Future research foci should be
on identifying opportunities for more cost-effective ways to eliminate onchocerciasis and to de-
velop innovative surveillance modalities for clinical LF for individual disease management and
disability prevention.
© 2020 The Authors. Published by Elsevier Ltd on behalf of World Federation of Parasitologists.
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Of the main filarial nematode diseases in sub-Saharan Africa, onchocerciasis caused by Onchocerca volvulus, and lymphatic
filariasis (LF) caused by Wuchereria bancrofti account for the greatest public health burden (World Health Organization, 2012a).
Onchocerciasis and LF are both endemic in the Republic of Angola and the national neglected tropical disease (NTD) programme
is working to scale-up preventive chemotherapy, by mass drug administration (MDA), to interrupt transmission with the long-
term aim of disease elimination (World Health Organization, 2016). However, there are several challenges, especially in areas
where loiasis, caused by the filarial nematode Loa loa exists (Vinkeles et al., 2020). In high L. loa prevalence communities,
large-scale MDA of ivermectin is not advised as life-threatening serious adverse events (SAEs) can occur in individuals with
high levels of L. loa microfilaraemia (Gardon et al., 1997; Zouré et al., 2011). This is of concern in low prevalence onchocerciasis
areas (i.e. hypo-endemic), that are co-endemic with a high prevalence of loiasis areas (i.e. hyper-endemic), as ivermectin is not
recommended and no safe, scalable alternative interventions are available (Bockarie et al., 2013).
In the northern Province of Bengo, Angola, there are areas where loiasis, onchocerciasis and LF are considered hypo-endemic,
which hampers current and future preventive chemotherapy activities of the NTD programme (Zouré et al., 2011; Casaca, 1966;
Brito et al., 2017). The most recent survey was conducted in 2014 using rapid clinical mapping methods, including the rapid ep-
idemiological assessment of onchocerciasis (REMO) (Noma et al., 2002), rapid assessment procedure for loiasis (RAPLOA) (Wanji
et al., 2012) and LF clinical indicators. Relatively low prevalences of loiasis (2.0%), onchocerciasis (5.3%) and LF (1.7%
lymphoedema; 0.8% hydrocele) were found, with no distinct geographical distribution. Nonetheless, this survey provided some
key preliminary data to the national programme, highlighting the need for further work to define community risk.
Standard epidemiological surveys traditionally use parasitological methods for detection of onchocerciasis (skin biopsies) or LF
(night blood thick films) but these techniques can be impractical, being labour intensive, insensitive, time consuming and/or in-
vasive (Wanji et al., 2016). To overcome the limitations of conventional microscopic diagnosis for filarial species identification,
serological and molecular diagnosis methods have been used as alternatives with varying levels of success (World Health
Organization, 2012a; Molyneux et al., 2016). In 2014, the main alternative method to serodiagnosis of loiasis was laboratory-
based polymerase chain reaction (PCR), for onchocerciasis the enzyme-linked immunosorbent assay (Ov16 ELISA) and for LF
the rapid diagnostic immunochromatographic test (ICT) and laboratory-based PCR (Weil and Ramzy, 2007; Kelly-Hope et al.,
2018a). Of note, these alternative methods are yet to be used in conjunction with one another and none have not been used
so far in Angola.
As a follow-up of the first filarial clinical mapping survey in Dande Municipality, Bengo Province (Brito et al., 2017), the objec-
tive of this current study was to examine the prevalence of filarial infections across the study areas using a combination of sero-
logical and molecular methods.
2. Methods
2.1. Study site and sampling
The study was conducted in the Centro de Investigacao em Saúde de Angola/Health Research Centre of Angola (CISA) Health
Demographic Surveillance System (HDSS-Dande), area of Dande Municipality, in the north-western province of Bengo, Angola
(Rosário et al., 2019) as a follow on from Brito et al., (2017). In this current study, 22 communities across the CISA area were se-
lected on the basis of their proximity to the rivers and vegetation to help target communities that might be at higher risk of on-
chocerciasis and loiasis.
In each community, at least 100 individuals aged ≥15 years were approached and invited to participate in the survey by the
field teams through house-to house visits. Following consent, a short questionnaire was administered in either Portuguese or
Kimbundo, the official and local languages, respectively. Demographic information was collected on the individual's age, sex,
length of residency and on clinical indicators for loiaisis (eye worm) and LF (limb lymphoedema, scrotal swelling due to
hydrocoele). In addition, individuals were asked if they had: i) seen the vector of L. loa, which was shown to them in a photo-
graph, to better understand if the Chrysops spp. was in the area; ii) taken MDA for onchocerciasis as some communities were
in a community directed treatment for ivermectin area (CDTI) defined by APOC and; iii) a mosquito net and had used it the
night before.
To determine prevalence of filarial infection through serological and molecular methods, 200 μL blood from each individual
was collected by venous puncture and stored in EDTA tubes. In the field during the survey, 100 μL blood was used for LF detection
using a rapid diagnostic test, and the remaining samples were kept in cooler boxes, before reaching the laboratory where two
dried blood spots were prepared on Whatman 3 M filter paper and the kept at 4 °C. The remaining 100 μL blood was used for
both LF real-time PCR and L. loa nested PCR.
2.2. Methods to infer prevalence
To determine the prevalence of L. loa, first the RAPLOA survey method was used, which is based on an individual's history of
eye worm. A restricted definition was defined as individuals answering positively to a three question survey including: i) their2
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(Zouré et al., 2011; Takougang et al., 2002).
Second, molecular biological methods were used to detect L. loa. Genomic DNA from the whole blood EDTA tubes using the
QIAamp® DNA Blood Kit (Qiagen, Hilden, Germany). Nested PCR for L. Loa detection was adapted from Jimenéz et al., (2011).
Briefly, a first PCR, targeted a 475 bp region of the ribosomal Internal Transcribed Space (ITS) DNA region common to different
nematode species was performed and visualized in 2.0% agarose gel electrophoresis. Positive samples were used in a second
PCR with L. loa specific primers giving 143 bp fragment, visualized in 2.0% agarose gel electrophoresis, confirming the L Loa infec-
tion. L. loa positive control was kindly provided by Professor Samuel Wanji, University of Buea, Cameroon.
To determine prevalence of the onchocerciasis parasite O. volvulus, dried blood spots were exported to the University of South
Florida, US for analysis of O. volvulus antigens by the Ov16 ELISA method. Blood spots were eluted and examined for the presence
of IgG4 antibodies recognizing the Ov16 antigen by ELISA, following standard procedures as described in Oguttu et al., (2014).
Data on the presence of nodules using the REMO method was not used in the study, so we were unable to compare REMO survey
data with the ELISA result (Brito et al., 2017). This is acknowledged as a limitation of the study.
To determine the prevalence of LF, first, the presence of main clinical conditions including limb lymphoedema (tissue swelling
or thickening), and hydrocoele (scrotal swelling) was identified by the field team and verified by a local medical officer. No se-
verity or staging of the condition was recorded. Second, the prevalence of W. bancrofti antigen was determined using the rapid
diagnostic immunochromatographic test (ICT) card (BinaxNOW Filariasis, (Alere, Portland, ME) with 100 μL blood). Tests were
conducted during the survey using the blood collected. At the time of the survey in 2014, the ICT diagnostic was the standard
recommended test for determining LF endemicity (World Health Organization, 2011), however, since then several studies have
shown that there is a cross-reactivity problem with the ICT diagnostic in communities with high L. loa prevalence, which can
lead to false positives (Bakajika et al., 2014; Pion et al., 2016). To account for possible cross-reactivity in the ICTs, the prevalence
of W. bancrofti DNA was determined using Genomic DNA extracted from the whole blood EDTA tubes using the Qiamp DNA Blood
kit (Qiagen, Hilden, Germany). Real-time PCR using specific primers and a Taqman® probe was used to detect W. bancrofti follow-
ing Rao et al., (2006), with thermal cycling conditions on a Bioarad CFX connect real time system instrument (Biorad). Amplifi-
cation controls included water (no DNA template) as a negative control, and gDNA from W. bancrofti microfilariae as a positive
control sample. W. bancrofti positive control was kindly provided by Professor Thomas R. Unnasch, University of South
Florida, USA.
2.3. Data analysis and mapping
All survey data were entered into Microsoft Excel 2010 by the CISA team, and the statistical software programme IBM SPSS
statistical version 21 was used for analysis. First, the prevalence for each community were quantified and mapped using ArcGIS
10.7 (ESRI, Redland CA). Second, the prevalence by length of residency (<5, 5–9, > 10 years), sex (male, female), and age
group (15–19, 20–29, 30–29, 40–49, 50–59, ≥60) were summarised and statistical differences examined using the chi-square
test (p-value considered significant at <0.05). Finally, data were examined overall and by sex and age groups (above/below
mean) to assess the relationship between i) L. loa eyeworm and infection and the knowledge of the Chrysops vector ii) onchocer-
ciasis and history of MDA and iii) LF and bed net ownership and usage.
2.4. Ethics and consent
The study was approved by the Angolan National Ethics Committee, administrative approval from the Ministry of Health of
Angola and the Liverpool School of Tropical Medicine Research Ethics Committee (Protocol 14.022). Written informed consent
was obtained from each individual and was orally explained if they were illiterate. For those who refused to participate, no further
questions were asked and no information was recorded. All people identified with clinical conditions or infections were informed
by the survey team or local community health worker and referred to the local health clinic for advice on self-care and treatment.
3. Results
The field survey was conducted in August 2014. In total, 22 communities, including 1616 individuals (10 to 168 per commu-
nity) were surveyed across the CISA area of Dande Municipality (Table 1.). In the majority of communities, it was difficult to reach
the targeted enrollment of 100 individuals, as people were either not present in the community or busy at work. Overall, there
were 615 males (38.1%) and 1001 females (61.9%) included in the survey, with an average age of 43 years, ranging from 15 to
90 years. The distribution of the communities and prevalence rates are shown in Fig. 1 A–D.
For RAPLOA, 6.2% of 1616 individuals surveyed were found to have eye worm based on the restricted eye worm definition in
21 communities (Table 1). The highest prevalence rates were found in Icau Wanda (18.3%) and Catutua (10.8%), while none were
reported from Lifune Nepasso (0.0%; Fig. 1A). Prevalence increased signficantly with length of residency from 3.0% in individuals
living <5 years to 7.8% in individuals living ≥10 years in the community (Chi-square = 10.962, p = 0.012) (Table 2). Overall,
there was no signficant difference between male 5.2% and female 6.8% prevalence rates. However, significant differences by age
group overall (Chi-square = 30.1 p < 0.001) and among females (Chi-square = 28.66, p < 0.001) were found, with the highest
prevalences in the >60 year age group (Table 3). When asked about the main Chrysops spp. vector, 11.2% (n = 179) of individuals
recognized the fly when presented with a photograph. Overall, males (12.8%), individuals aged >43 years (27.3%) and those with3
Table 1
Summary of loiasis, onchocerciasis and LF serological and molecular prevalence by community.







No Clinical† ICT PCR
Acucareira Sede 168 6.0 166 8.3 168 3.0 168 1.8 0.0 0.0
Boa Esperanca 2 97 7.2 96 8.3 97 0 97 3.1 0.0 0.0
Catuta 65 10.8 63 0.0 64 17.2 65 3.1 0.0 0.0
Coragem 93 9.7 92 2.2 92 2.2 93 1.1 0.0 0.0
Honga Hungo 74 6.8 74 1.4 73 1.3 74 1.4 0.0 0.0
Icau Centro 38 5.3 36 50.0 35 8.6 38 2.6 0.0 0.0
Icau Wanda 16 18.3 16 0.0 16 18.8 16 6.3 0.0 0.0
Jungo 59 5.1 56 5.4 59 1.7 59 0.0 0.0 0.0
Kicola 84 3.6 82 28.0 81 1.2 84 1.2 0.0 0.0
Kilometro 29 78 3.8 43 0.0 72 0.0 78 1.3 0.0 0.0
Kixiquela 60 6.7 44 18.2 58 0.0 60 0.0 0.0 0.0
Lifune Nepasso 45 0 44 4.5 45 35.6 45 4.4 0.0 0.0
Mabubas Sede 110 6.4 110 0.0 105 2.9 110 0.9 0.0 0.0
Muculo 58 5.2 58 5.2 57 5.3 58 0.0 0.0 0.0
Mussenga 88 8.0 85 1.2 88 9.1 88 0.0 0.0 0.0
Paranhos 71 7.0 69 66.7 66 3.0 71 4.2 0.0 0.0
Rio Seco 71 5.6 70 1.4 51 13.7 71 1.4 0.0 0.0
Santa Rosa 10 10.0 10 0.0 10 0.0 10 0.0 0.0 0.0
Sassa Povoacao 148 6.8 147 24.5 147 0.7 148 2.0 0.0 0.0
Sorilo 49 4.1 49 2.0 49 0.0 49 0.0 0.0 0.0
Sosso 55 3.6 53 20.8 55 0.0 55 3.6 0.0 0.0
Tres Casas 79 3.8 78 0.0 79 8.9 79 1.3 0.0 0.0
Total 1616 6.2 1543 11.5 1567 4.7 1616 1.7 0.0 0.0
Note: Grey shade indicates above average prevalence measures.
† Includes limb lymphoedema and/or hydrocoele (scrotal swelling).
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worm 11.4%). Males with eye worm history were more likely to recognize the Chrysop vector in comparison with those with no
eye worm history (Table 4).
For L. loa nested PCR, 11.5% of 1543 individuals tested were found to be positive in 16 communities (Table 1). The highest
rates were found in Icau Centro (50.0%), and Paranhos (66.7%); no positives found in Catuta, Icau Wanda, Kilômetro 29, Mabubas
Sede, Santa Rosa and Três Casas (Fig. 1B). Prevalence did not signficantly differ with length of residency (Table 2) or by sex (males
11.3%; females 11.7%). However, signficant differences by age groups were found overall (Chi-square = 36.708, p = 0.000) and
among males (chi-square = 22.051, p = 0.001) and females (chi-square = 19.517, p = 0.002), with the highest prevalences in
the 15–19 year age group (Table 3). Taking infections status into account, when asked about the main Chrysops spp. vector, no
signficant differences were found by sex and age (Table 4). Overall, the relationship between the RAPLOA and nested PCR was
not significant with only eight RAPLOA positive individuals also positive by PCR.
For onchocerciasis, 4.7% of 1567 individuals tested were found to be positive in 16 communities (Table 1). The highest prev-
alence rates were found in Lifune Nepasso (35.6%) and Icau Wanda (18.8%), while no positves were detected in Boa Esperança 2,
Kilômetro 29, Kixiquela, Santa Rosa, Sorilo and Sosso (Fig. 1C). Prevalence did not signficantly differ with length of residency or by
sex (males 5.0%; females 4.6%) overall (Table 2). Similarly, no significant differences by age group overall or among males and
females were found (Table 3). Three individuals (0.2%) from Coregem (female, 59 years), Hongo Hungo (male, 41 years, positive
ELISA) and Lifune Nepasso (male, 21 years) reported they had taken a drug for onchocerciasis, 68.8% reported they had not, and
the remaining individuals did not know.
For LF, none of the 1616 individuals surveyed were found to be positive for LF antigen or by real-time PCR (Table 1). However,
1.7% were found to have lymphoedema and/or hydrocoele in 16 communities (Table 1). In total, 11 cases of lymphoedema4















Summary of loiasis, onchocerciasis and LF by length of residency†.
Village RAPLOA L. loa Oncho LF
N % N % N % N %
< 5 years 401 3.0 364 12.4 380 3.4 401 0.7
5 to 9 years 421 6.2 386 8.8 401 5.7 421 0.5
≥ 10 years 791 7.8 793 12.5 777 4.9 791 1.4
p = 0.012 Ns Ns Ns
Total 1616 6.2 1543 12.0 1567 4.7 1613 0.9
† 3 missing answers.
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highest number of cases were identified in Sassa Povoação (3 lymphoedema; 1 hydrocoele), Açucareira Sede (1 lymphoedema,
2 hydrocoele) and Boa Esperança 2 (3 hydrocoele), Sosso (2 lymphoedema,1 hydrocoele) and Catutua (1 lymphoedema and 1
hydrocoele), Lifune Nepasso (1 lymphodema and 1 hydrocoele). One lymphodema case was found in Coragem, Icau Centro,
Kilômetro 29, and Rio Reco and one hydrocoele case found in Honga Hunga, Icau Wanda, Kicola, Mabubas Sede, and Três
Casas. Prevalence did not significantly differ with length of residency or for lymphoedema by sex (males 1.2%; females 0.6%)
(Table 2). Similarly, no significant differences by age group overall or among males and females were found (Table 3).
Overall, 735 individuals (45.5%) reported they owned a bed net, 860 (53.2%) did not and 21 (1.2%) did not answer the ques-
tion. There were significant differences between males (50.1%) and females (43.6%) and between younger (43.1%) and older
(49.3%) individuals (Chi-square = 6.28, p = 0.012), but not between individuals affected and not affected by LF clinical condtions.
With respect to bednet usage, 71.1% of those who owned a bed net reported they slept under it the previous night. Overall, there
were signficant differences between males (75.2%) and females (68.2%)(Chi-square = 4.151, p = 0.04) in bed net usage, but not
by age or clinical condition.4. Discussion
Our survey used a combination of clinical, serological and molecular diagnostics to confirm the low levels of filarial endemicity
across the CISA study area within Dande Municipality (Brito et al., 2017). This will help to inform the Angola NTD programme on
appropriate, safe and better tailored intervention strategies locally, taking the widespread loiasis prevalence into account. This is
particularly important for onchocerciasis, which was found to be hypo-endemic as previously reported (Brito et al., 2017) (see
supplementary file 2). As a result ivermectin MDA is not recommended due to the risk of SAEs (Zouré et al., 2011). Currently,
no alternative drugs are available for these hypo-endemic onchocerciasis ‘hotspot’ areas, and only a few individuals indicated
that they had taken ivermectin, so the SAE risk is relatively unknown. However, the CISA area may be suitable for the new
Test-and-Not-Treat (TNT) strategy that includes the use of the Loascope to help make a diagnosis and direct the most appropriateTable 3
Prevalence of loiasis, onchocerciasis and LF overall and by sex and age group
RAPLOA L. loa PCR Onchocerciasis LF clinical†
Age class N % N % N % N %
Overall 15 to 19 190 2.6 78 21.9 176 2.3 190 1.1
20 to 29 313 3.2 301 15.6 305 5.6 313 0.3
30 to 39 247 4.0 235 11.5 239 5.4 247 0.0
40 to 49 249 5.6 235 7.2 241 4.1 249 2.0
50 to 59 307 7.8 294 7.5 300 5.0 307 1.6
>60 310 11.9 300 8.7 306 4.9 310 1.0
p=0.000 p=0.000 Ns Ns
Male 15 to 19 86 2.3 81 22.2 77 3.9 86 2.3
20 to 29 103 3.9 100 18.0 98 4.1 103 0.0
30 to 39 90 4.4 86 8.1 85 4.7 90 0.0
40 to 49 96 6.3 94 9.6 91 6.6 96 4.2
50 to 59 124 4.8 120 5.8 118 4.2 124 3.2
>60 116 8.6 112 7.1 114 6.1 116 1.7
Ns p=0.001 Ns Ns
Female 15 to 19 104 2.9 97 21.6 99 1.0 104 0.0
20 to 29 210 2.9 201 14.4 207 6.3 210 0.5
30 to 39 157 3.8 149 13.4 154 5.8 157 0.0
40 to 49 153 5.2 141 5.7 150 2.7 153 0.7
50 to 59 183 9.8 174 8.6 182 5.5 183 0.5
>60 194 13.9 188 9.6 192 4.2 194 0.5
P=0.000 p=0.002 Ns Ns
† Includes limb lymphoedema and/or hydrocoele (scrotal swelling) in overall measure and for males.
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Table 4
Summary of the knowledge of Chrysops vector overall and by sex and age group.
Village Have you seen this fly? RAPLOA L. loa PCR
Overall N† % N†† %
Yes 179 11.2 168 9.5
No 1301 5.1 1251 12.2
p=0.001 Ns
Male Yes 94 12.8 62 11.3
No 466 3.6 477 17.2
p=0.000 Ns
Female Yes 85 9.4 106 8.5
No 835 5.9 774 9.0
Ns Ns
<43 yrs Yes 20 10.0 62 11.3
No 747 9.2 477 17.2
Ns Ns
>43 yrs Yes 66 27.3 106 8.5
No 647 13.9 774 9.0
p=0.004 Ns
† 1480 included as 136 answers missing.
†† 1419 included as 120 answers missing.
R. Paulo, M. Brito, P. Van-Dunem et al. Parasite Epidemiology and Control 11 (2020) e00183treatment regimen depending on the individual's infection status (Kamgno et al., 2018; Boussinesq et al., 2018). This area was
previously considered to be a high-risk area for SAEs (Takougang et al., 2002). Therefore, further confirmation of the onchocerci-
asis distribution through skin snipping or use of other diagnostics (Kelly-Hope et al., 2018a) may be neccesary. Before or during
an alternative strategy such as TNT is conducted.
The prevalence of loiasis using the RAPLOA method was found to be widespread, and higher than in the previous survey by
Brito et al., (2017) (Supplementary Table 1). The reason for this difference in prevalence is unclear, but may be due to different
populations being sampled, seasonality and people being away for work at different times of the year. This is a mobile population
that frequently visits the town Caxito (Rosário et al., 2019). The difference between loiasis and the L. loa nested-PCR prevalence
was also surprising with little correlation between the tests and higher L. loa PCR prevalence in younger age groups. The impli-
cations of this and how it relates to L. loa mf intensity and risk SAEs is unclear as this study was limited and did not include par-
asitological analysis; however it may suggest that the positive results in younger population indicate recent transmission of L. loa
in the area. Furthermore, it may be that younger people who are infected may be new or mobile residents and not exposed
enough to experience eyeworm, which was more evident in longer term and older residents. The higher risk of eyeworm in pos-
itive and older individuals, especially males, may be related to their occupation and visits to forested areas as they were more
likely to recognize the Chrysops vector, also known as the readily identifiable Red Fly in Africa (Kelly-Hope et al., 2017a). More
frequent forest visits have been associated with an increased risk in loiasis (Mischlinger et al., 2018; Brant et al., 2018), and
using local knowledge to determine risk zones in communities and workplaces may also help to identify vector habitats. Cur-
rently, no data exists on the Chrysops vector in Angola (Kelly-Hope et al., 2017a), however C. dimidiata and C. longicornis have
been implicated (Hawking, 1974), which may have different ecological niches to other parts of Central Africa.
The lack of LF serological and molecular positive individuals and the few related clinical cases further indicates that this a non-
endemic or very low endemic area for LF, which is in accordance with historical data and recent mapping surveys from 2005 and
2010 (Casaca, 1966; Brito et al., 2017), and as such may not require MDA. It is also possible that the lymphoedema and
hydrocoele cases are not related to LF, and different clinical algorithms may be needed in areas of uncertainty (Deribe et al.,
2018). It is important that Angola's NTD programme uses this data to consult with the WHO as it could help to shrink the
map by reducing the number of endemic municipalities throughout the country. This will save time and resources and consider
more appropriate surveillance strategies for low prevalence areas (Riches et al., 2020; Kelly-Hope et al., 2017b), especially in
loiasis co-endemic areas where there is increasing evidence of low LF prevalence (Wanji et al., 2019; Kelly-Hope et al., 2018b).
Engagement with the national malaria control programme to help increase the bed net coverage in the area will be critical as
this can reduce W. bancrofti transmission (Rebollo et al., 2015; Berg et al., 2012; Bockarie et al., 2009), and is a WHO recom-
mended alternative strategy in loiasis co-endemic areas (World Health Organization, 2011; World Health Organization, 2012b).
Overall, the number of patients was low and health workers need to be trained to provide care to patients, including home-
based self-care for lymphoedema, with subsequent referral if needed for surgical management of hydrocele, as it can improve pa-
tient economic and quality of life outcomes (World Health Organization, 2013; World Health Organization, 2019; Betts et al.,
2020).
This study highlights an integrated approach including how an alternative range of molecular and serological diagnostic tools
can better define the filarial prevalence across the CISA study areas. The reason for different geographical distributions may be7
R. Paulo, M. Brito, P. Van-Dunem et al. Parasite Epidemiology and Control 11 (2020) e00183related to environmental factors; however, Molyneux et al., (2014) has suggested the possibility of competitive exclusion where if
the three human filaria are present then their interactions might reduce the intensity of all infections due to factors such as niche
separation, periodicity, immunity, geographical distribution of the parasites, ecological barriers. Nonetheless, focus now needs to
be on devising opportunities to implement a practical and cost-effective strategy to eliminate onchocerciasis and conduct innova-
tive surveillance for LF in the area. All of this will, of course, require collaboration between programmes, the community, national
partners and international stakeholders (Colebunders et al., 2019).
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